Chemoinformaics analysis of BARRINGTOGENOL-C-21-ANGELATE
| Molecular Weight | 572.827 | nRot | 3 |
| Heavy Atom Molecular Weight | 516.379 | nRig | 28 |
| Exact Molecular Weight | 572.408 | nRing | 5 |
| Solubility: LogS | -4.124 | nHRing | 0 |
| Solubility: LogP | 4.708 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 97 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 56 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 35 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 100.602 |
| nHD | 4 | BPOL | 58.7836 |
| QED | 0.2 |
| Synth | 5.293 |
| Natural Product Likeliness | 3.472 |
| NR-PPAR-gamma | 0.659 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.984 |
| Pgp-sub | 0.011 |
| HIA | 0.101 |
| CACO-2 | -4.871 |
| MDCK | 0.0000165 |
| BBB | 0.975 |
| PPB | 0.935414 |
| VDSS | 1.357 |
| FU | 0.0533385 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.127 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.922 |
| CYP2c9-inh | 0.112 |
| CYP2c9-sub | 0.337 |
| CYP2d6-inh | 0.041 |
| CYP2d6-sub | 0.21 |
| CYP3a4-inh | 0.345 |
| CYP3a4-sub | 0.362 |
| CL | 10.526 |
| T12 | 0.021 |
| hERG | 0.005 |
| Ames | 0.02 |
| ROA | 0.093 |
| SkinSen | 0.014 |
| Carcinogencity | 0.012 |
| EI | 0.047 |
| Respiratory | 0.973 |
| NR-Aromatase | 0.826 |
| Antiviral | Yes |
| Prediction | 0.611557 |